Fig. 7From: Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligandsPlot of cell viability % versus concentration of (a) PCHD, [Cu(PCHD)2]ClO4.H2O and (b) PyCHD, [Cu(PyCHD)2]ClO4.H2O, against MCF-7, compared with CisplatinBack to article page